Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB05190"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"XL281"
|
| rdf:type | |
| drugbank:description |
"XL281 is a novel anticancer compound designed to potently inhibit the RAS/RAF/MEK/ERK signaling pathway. Mutational activation of RAS occurs in about 30 percent of all human tumors, including non-small cell lung, pancreatic, and colon cancer. XL281 is a specific inhibitor of RAF kinases, including the mutant form of B-RAF, which is activated in 60 percent of melanomas, 24-44 percent of thyroid cancers, and 9 percent of colon cancers.
"
|
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource does not appear as an object